Navigation Links
Radiation for Prostate Cancer Raises Risk of Other Cancers
Date:5/19/2008

Study finds slightly elevated chance of bladder, colorectal and lung malignancies

MONDAY, May 19 (HealthDay News) -- Men undergoing external beam radiation for localized prostate cancer may have a slightly increased risk of developing other cancers, researchers report.

The findings could have implications for men trying to decide which treatment is best for their prostate cancer, the researchers said.

"We saw an increased risk for lung, bladder and rectal cancer among patients treated with external beam radiation for prostate cancer," lead researcher Dr. Naeem Bhojani, from the University of Montreal's Department of Urology, said during a Monday teleconference at the American Urological Association annual meeting, in Orlando, Fla.

"However, in absolute terms, the absolute risk associated with the development of secondary malignancies in patients exposed to external beam radiation therapy is quite small," Bhojani said.

Among the treatments for prostate cancer are surgical removal of the prostate, called radical prostatectomy; implanted radioactive seeds that deliver radiation specifically to the prostate gland; and external beam radiation, which is a non-surgical procedure that delivers radiation to the prostate from outside the body.

Bhojani said external beam radiation is probably a better treatment choice for older patients rather than younger patients with longer life expectancies, who may be at risk for developing these secondary cancers.

For the study, by researchers from Canada, Italy and the United States, Bhojani's group collected data on 10,333 men being treated for localized prostate cancer. Among these men, 6,196 had their prostate surgically removed, and 4,137 underwent external beam radiation.

The researchers then looked at the later development of bladder, lung and rectal cancer, to see which treatment was more likely to increase the risk of these malignancies.

They found that men who'd undergone external beam radiation had a threefold increased rate of bladder cancer, a 1.8-fold increased rate of lung cancer, and a 1.7-fold increased rate of colorectal cancer, compared with men who underwent radical prostatectomy.

One cancer expert said he couldn't explain why external beam radiation would increase the risk of these cancers, especially lung cancer.

"I'm not sure how external beam radiation to the pelvis for prostate cancer would increase the risk for lung cancer," said Dr. Bruce Roth, professor of medicine and urologic surgery at Vanderbilt University.

The radiation therapy would be more likely to increase the risk for bladder cancer and colorectal cancer, which are nearer the prostate, he noted.

Roth said it's important to give prostate cancer patients several treatment choices. "I will give them a number of options and let them pick based on the side effect profile. There are many patients who may not be good surgical candidates, therefore you might lean toward external beam radiotherapy," he said.

In another study presented Monday, researchers found that survivors of childhood cancers treated with the chemotherapy drug cyclophosphamide were five times likelier to develop bladder cancer later in life, compared with the general population.

Children up to 4 years old treated with the drug for retinoblastoma, leukemia and non-Hodgkin lymphoma had a particular risk for developing bladder cancer, the researchers found.

Cyclophosphamide is an immunosuppressive drug used to treat several types of cancers and is known to cause bladder damage that can lead to bladder cancer.

In patients followed for up to 50 years, the researchers found that the chances of developing bladder cancer increased over time. The percentage of patients diagnosed with bladder cancer at 20, 30, 40 and 50 years of age was 0.02 percent, 0.08 percent, 0.37 percent and 0.71 percent, respectively, the researchers reported.

More information

For more about prostate cancer, visit the National Cancer Institute.



SOURCES: Bruce Roth, M.D., professor, medicine and urologic surgery, Vanderbilt University, Nashville, Tenn.; May 19, 2008, teleconference with Naeem Bhojani, M.D., University of Montreal, Quebec, Canada; May 19, 2008, presentation, American Urological Association annual meeting, Orlando, Fla.


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Black Rectal Cancer Patients Less Likely to Get Chemo, Radiation
2. Space Radiation a Risk for Astronauts
3. Radiation beneficial for older breast cancer patients
4. Irradiation Almost Erases Risk of Food Poisoning
5. New Drug Protects Against Radiation Damage
6. Environmental Toxins, Radiation May Be Tied to Breast Cancer
7. Breast Cancer Radiation Therapy Works in Fewer, But Higher Doses
8. Ambulatory Services of America, Inc. Announces Joint Venture with Southern Ocean County Radiation Oncology, LLC
9. Study Finds Variations in Doses of Radiation Therapy
10. American Imaging Management Launches Patient Safety Program to Increase Awareness of Radiation Dose Associated with Advanced Imaging Procedures
11. Venture Global Limited Introduces an Innovative Anti-Cellphone Radiation Sticker Named VEGO Power Blocker
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 26, 2016 One of Australia,s ... the formation of a new biotechnology company, Noxopharm Limited [ABN 50 ... an IPO and to list on the ASX. Noxopharm ... ready to enter a Phase 1 clinical study later this year. ... address one of the biggest problems facing cancer patients - the ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: